StockData
TTIPFOTCFiscal year ends February 28

Thiogenesis Therapeutics, Corp.

$0.37+0.00 (0.00%)

Close on Oct 16, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

SEC filings

0 of Thiogenesis Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource